We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sphere Medical | LSE:SPHR | London | Ordinary Share | GB00B551W951 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.40 | 0.35 | 0.45 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMSPHR
RNS Number : 1624W
Sphere Medical Holding plc
07 February 2017
7 February 2017
Sphere Medical Holding plc
("Sphere Medical" or the "Company")
Notice of Preliminary Results
Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, will announce its preliminary results for the year ended 31 December 2016 on Tuesday 28 February 2017.
Dr. Wolfgang Rencken, Chief Executive Officer and Richard Wright, Chief Financial Officer, will host a presentation and conference call for analysts at 9.30am GMT on the day of the results at Panmure Gordon's offices, One New Change, London, EC4M 9AF.
- Ends -
For further information, please contact:
Hot Features
Premium
Sphere Medical Holding Tel: +44 (0)1223 875
plc 222
Dr Wolfgang Rencken, Chief
Executive Officer
Richard Wright, Chief
Financial Officer
Panmure Gordon Tel: +44 (0) 20 7886
2500
Freddy Crossley (Corporate
Finance)
Duncan Monteith (Corporate
Finance)
Tom Salvesen (Corporate
Broking)
Consilium Strategic Tel: +44 (0) 20 3709
Communications 5700
Mary-Jane Elliott spheremedical@consilium-comms.com
Ivar Milligan
Hendrik Thys
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium and via distributors in Italy and Spain. For further information, please visit www.spheremedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORUGUAPPUPMGMQ
(END) Dow Jones Newswires
February 07, 2017 02:00 ET (07:00 GMT)
1 Year Sphere Medical Chart |
1 Month Sphere Medical Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
